Independent Director · Coherus Oncology, Inc. (CHRS)

Chair, Audit Committee

Rita A. Karachun director compensation at Coherus Oncology: $139K

Fiscal year 2025 director compensation for Rita A. Karachun at Coherus Oncology, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 20, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Rita A. Karachun’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Rita A. Karachun and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Coherus Oncology Director Compensation Table · the one fiscal year held
In US dollars, as Coherus Oncology reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$77,500—$61,667—$139,167

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Coherus Oncology, Inc. DEF 14A filed April 20, 2026, accession 0001104659-26-045251, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Coherus Oncology, Inc. filed document, accession 0001104659-26-045251. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2026.

Get the Coherus Oncology Board Governance Report

$139,167 Rita A. Karachun, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 20, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Coherus Oncology pays directors a $50,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit (Chair)

The rest of the Coherus Oncology board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Ali J. SatvatIndependent Director$144,167
Charles W. NewtonIndependent Director$144,167
Dennis M. LanfearChair of the Board—
Georgia ErbezIndependent Director$134,167
Jill O'Donnell-Tormey, Ph.DIndependent Director$116,667
Lee N. Newcomer, MDIndependent Director$121,667
Mats L. WahlströmLead Independent Director$191,667
Michael RyanIndependent Director$131,042

The full Coherus Oncology compensation record

free company brief

This page is one director within Coherus Oncology's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Coherus Oncology proxy · each links to its own free brief

Order CHRS

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report